Loading clinical trials...
Loading clinical trials...
NGR005: Pilot Study of NGR-hTNF Administered at Low and High Doses in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Conditions
Interventions
NGR-hTNF
Oxaliplatin
+1 more
Locations
1
Italy
Azienda Ospedaliera Universitaria San Martino
Genoa, Genoa, Italy
Start Date
December 1, 2007
Primary Completion Date
December 1, 2010
Completion Date
May 1, 2013
Last Updated
May 30, 2014
NCT04704661
NCT04674267
NCT04668872
NCT05672108
NCT07321106
NCT06051695
Lead Sponsor
AGC Biologics S.p.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions